Pfizer Inc (PFE): Today's Featured Drugs Winner
(
) pushed the Drugs industry higher today making it today's featured drugs winner. The industry as a whole closed the day up 3.2%. By the end of trading, Pfizer Inc rose 64 cents (3.5%) to $19.09 on average volume. Throughout the day, 40 million shares of Pfizer Inc exchanged hands as compared to its average daily volume of 47.1 million shares. The stock ranged in a price between $18.77-$19.10 after having opened the day at $18.81 as compared to the previous trading day's close of $18.45. Other companies within the Drugs industry that increased today were:
(
), up 27.5%,
(
), up 20.5%,
(
), up 18.2%, and
Rosetta Genomics
(
ROSGD
), up 18.2%.
Pfizer Inc., a biopharmaceutical company, offers prescription medicines for humans and animals worldwide. Pfizer Inc has a market cap of $145.28 billion and is part of the
sector. The company has a P/E ratio of 14.5, above the average drugs industry P/E ratio of 13 and below the S&P 500 P/E ratio of 17.7. Shares are up 5.4% year to date as of the close of trading on Friday.
TheStreet Ratings rates Pfizer as a
. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, attractive valuation levels and compelling growth in net income. We feel these strengths outweigh the fact that the company shows weak operating cash flow.
- You can view the full Pfizer Ratings Report.
- Use our drugs section to find industry-relevant news.
- Or find some new ideas from our top rated stocks lists.
For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the drugs industry could consider
(
) while those bearish on the drugs industry could consider
ProShares UltraShort Nasdaq Biotech
(
).
- Find other investment ideas from our top rated ETFs lists.
null
